C-Kit+ progenitors generate vascular cells for tissue-engineered grafts through modulation of the Wnt/Klf4 pathway

Biomaterials

Volumn 60, Issue , 2015, Pages 53-61

  Campagnolo, Paola ^a   Tsai, Tsung Neng ^b   Hong, Xuechong ^b   Kirton, John Paul ^b   So, Po Wah ^c   Margariti, Andriana ^b   Di Bernardini, Elisabetta ^b   Wong, Mei Mei ^b   Hu, Yanhua ^b   Stevens, Molly M ^a   Xu, Qingbo ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cell signalling; Endothelialization; Stem cells; Vascular graft

Indexed keywords

CELL SIGNALING; CYTOLOGY; ENDOTHELIAL CELLS; GRAFTS; LITHIUM CHLORIDE; MUSCLE; STEM CELLS; TRANSCRIPTION;

CELL SIGNALLING; EMBRYONIC STEM CELLS; ENDOTHELIALIZATION; SMALL DIAMETER VASCULAR GRAFTS; SMOOTH MUSCLE CELLS; TISSUE ENGINEERED VASCULAR GRAFTS; TISSUE-ENGINEERED GRAFTS; VASCULAR GRAFTS;

SCAFFOLDS (BIOLOGY);

ATAXIN 1; BETA CATENIN; KRUPPEL LIKE FACTOR 4; LITHIUM CHLORIDE; WNT PROTEIN; KRUPPEL LIKE FACTOR; LY ANTIGEN; LY6A PROTEIN, MOUSE; MEMBRANE PROTEIN; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL GRAFT; CELL FATE; EMBRYONIC STEM CELL; EX VIVO STUDY; GENE TARGETING; IN VIVO STUDY; INVESTIGATIVE PROCEDURES; MOUSE; NEOINTIMA; NONHUMAN; ONCOGENE C KIT; PRIORITY JOURNAL; SHEAR STRESS; TISSUE ENGINEERING; WNT SIGNALING PATHWAY; ANIMAL; BLOOD VESSEL PROSTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; METABOLISM; PROCEDURES; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIGENS, LY; BLOOD VESSEL PROSTHESIS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; EMBRYONIC STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MEMBRANE PROTEINS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTO-ONCOGENE PROTEINS C-KIT; TISSUE ENGINEERING; WNT SIGNALING PATHWAY;

EID: 84930442389     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.04.055     Document Type: Article

References (39)

1. Seifu D.G., Purnama A., Mequanint K., Mantovani D. Small-diameter vascular tissue engineering. Nat. Rev. Cardiol. N. D. 2013, 10:410-421.
2. Tsai T.-N., Kirton J.P., Campagnolo P., Zhang L., Xiao Q., Zhang Z., Wang W., Hu Y., Xu Q. Contribution of stem cells to neointimal formation of decellularized vessel grafts in a novel mouse model. Am. J. Pathol. 2012, 181:362-373.
3. Gong Z., Niklason L.E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 2008, 22:1635-1648.
4. Karamariti E., Margariti A., Winkler B., Wang X., Hong X., Baban D., Ragoussis J., Huang Y., Han J.-D.J., Wong M.M., Sag C.M., Shah A.M., Hu Y., Xu Q. Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signaling are potent for tissue engineering of vascular grafts. Circ. Res. 2013, 112:1433-1443.
5. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., Leri A., Kajstura J., Nadal-Ginard B., Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
6. Limana F., Zacheo A., Mocini D., Mangoni A., Borsellino G., Diamantini A., De Mori R., Battistini L., Vigna E., Santini M., Loiaconi V., Pompilio G., Germani A., Capogrossi M.C. Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ. Res. 2007, 101:1255-1265.
7. Gambini E., Pompilio G., Biondi A., Alamanni F., Capogrossi M.C., Agrifoglio M., Pesce M. C-kit+ cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment. Cardiovasc. Res. 2011, 89:362-373.
8. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
9. Yoshida T., Kaestner K.H., Owens G.K. Conditional deletion of kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ. Res. 2008, 102:1548-1557.
10. Kunes P., Holubcová Z., Krejsek J. Occurrence and significance of the nuclear transcription factor Krüppel-like factor 4 (KLF4) in the vessel wall. Acta Medica (Hradec Kralove) 2009, 52:135-139.
11. Liu Y., Sinha S., Owens G. Atransforming growth factor-β control element required for SM α-actin expression invivo also partially mediates GKLF-dependent transcriptional repression. J.Biol. Chem. 2003, 278:7.
12. Liu Y., Sinha S., McDonald O.G., Shang Y., Hoofnagle M.H., Owens G.K. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J.Biol. Chem. 2005, 280:9.
13. Ohnesorge N., Viemann D., Schmidt N., Czymai T., Spiering D.S.E., Schmolke M., Ludwig S., Roth J., Goebeler M., Schmidt M. Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kr√°ppel-like factor 4 (KLF4). J.Biol. Chem. 2010, 285:26199-26210.
14. Villarreal G., Zhang Y., Larman H.B., Gracia-Sancho J., Koo A., Garcia-Cardena G. Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells. Biochem. Biophys. Res. Commun. 2010, 391:984-989.
15. Orlando G., Wood K.J., De Coppi P., Baptista P.M., Binder K.W., Bitar K.N., Breuer C., Burnett L., Christ G., Farney A., Figliuzzi M., Holmes J.H., Koch K., Macchiarini P., Mirmalek Sani S.-H., Opara E., Remuzzi A., Rogers J., Saul J.M., Seliktar D., Shapira-Schweitzer K., Smith T., Solomon D., Van Dyke M., Yoo J.J., Zhang Y., Atala A., Stratta R.J., Soker S. Regenerative medicine as applied to general surgery. Ann. Surg. 2012, 255:867-880.
16. Cowan C.E., Kohler E.E., Dugan T.A., Mirza M.K., Malik A.B., Wary K.K. Kruppel-like factor-4 transcriptionally regulates VE-cadherin expression and endothelial barrier function. Circ. Res. 2010, 107:959-966.
17. McCormick S.M., Eskin S.G., McIntire L.V., Teng C.L., Lu C.-M., Russell C.G., Chittur K.K. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc. Natl. Acad. Sci. 2001, 98:8955-8960.
18. Clark P.R., Jensen T.J., Kluger M.S., Morelock M., Hanidu A., Qi Z., Tatake R.J., Pober J.S. MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells. Microcirculation 2011, 18:102-117.
19. Yet S.-F., McA'Nulty M.M., Folta S.C., Yen H.-W., Yoshizumi M., Hsieh C.-M., Layne M.D., Chin M.T., Wang H., Perrella M.A., Jain M.K., Lee M.-E. Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J.Biol. Chem. 1998, 273:1026-1031.
20. Yang D.-H., Yoon J.-Y., Lee S.-H., Bryja V., Andersson E.R., Arenas E., Kwon Y.-G., Choi K.-Y. Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/beta-catenin and protein kinase calpha. Circulation Res. 2009, 104:372-379.
21. Corada M., Nyqvist D., Orsenigo F., Caprini A., Giampietro C., Taketo M.M., Iruela-Arispe M.L., Adams R.H., Dejana E. The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/notch signaling. Dev. Cell. 2010, 18:938-949.
22. Skurk C., Maatz H., Rocnik E., Bialik A., Force T., Walsh K. Glycogen-synthase kinase3/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circulation Res. 2005, 96:308-318.
23. Zeng L., Xiao Q., Margariti A., Zhang Z., Zampetaki A., Patel S., Capogrossi M.C., Hu Y., Xu Q. HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J.Cell Biol. 2006, 174:1059-1069.
24. Margariti A., Zampetaki A., Xiao Q., Zhou B., Karamariti E., Martin D., Yin X., Mayr M., Li H., Zhang Z., De Falco E., Hu Y., Cockerill G., Xu Q., Zeng L. Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin. Circulation Res. 2010, 106:1202-1211.
25. Zhang W., Chen X., Kato Y., Evans P.M., Yuan S., Yang J., Rychahou P.G., Yang V.W., He X., Evers B.M., Liu C. Novel cross talk of kruppel-like factor 4 and β-catenin regulates normal intestinal homeostasis and tumor repression. Mol. Cell. Biol. 2006, 26:2055-2064.
26. Evans P.M., Chen X., Zhang W., Liu C. KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin. Mol. Cell. Biol. 2010, 30:372-381.
27. Eagle K.A., Guyton R.A., Davidoff R., Edwards F.H., Ewy G.A., Gardner T.J., Hart J.C., Herrmann H.C., Hillis L.D., Hutter A.M., Lytle B.W., Marlow R.A., Nugent W.C., Orszulak T.A., Antman E.M., Smith S.C., Alpert J.S., Anderson J.L., Faxon D.P., Fuster V., Gibbons R.J., Gregoratos G., Halperin J.L., Hiratzka L.F., Hunt S.A., Jacobs A.K., Ornato J.P. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. Circulation 2004, 110:1168-1176.
28. Xiao Q., Zeng L., Zhang Z., Margariti A., Ali Z.A., Channon K.M., Xu Q., Hu Y. Sca-1+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2244-2251.
29. Xiao Q., Zeng L., Zhang Z., Hu Y., Xu Q. Stem cell-derived Sca-1+ progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin {alpha}1/beta1/{alpha}v and PDGF receptor pathways. Am. J. Physiol. Cell. Physiol. 2007, 292:C342-C352.
30. Martin N.D., Schaner P.J., Tulenko T.N., Shapiro I.M., DiMatteo C.A., Williams T.K., Hager E.S., DiMuzio P.J. Invivo behavior of decellularized vein allograft. J.Surg. Res. 2005, 129:17-23.
31. Shen B., Smith R.S., Hsu Y.-T., Chao L., Chao J. Kruppel-like factor 4 is a novel mediator of kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression. J.Biol. Chem. 2009, 284:7.
32. Pasic M., Müller-Glauser W., Segesser von L.K., Lachat M., Mihaljevic T., Turina M.I. Superior late patency of small-diameter Dacron grafts seeded with omental microvascular cells: an experimental study. Ann. Thorac. Surg. 1994, 58. 677-83-discussion683-4.
33. Drukker M., Katchman H., Katz G., Even-Tov Friedman S., Shezen E., Hornstein E., Mandelboim O., Reisner Y., Benvenisty N. Human embryonic stem cells and their differentiated Derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006, 24:221-229.
34. Bhattacharya V., McSweeney P.A., Shi Q., Bruno B., Ishida A., Nash R., Storb R.F., Sauvage L.R., Hammond W.P., Wu M.H.-D. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34+ bone marrow cells: presented to the Western Vascular Society, Whistler, BC, Canada. Blood September 11, 1998, 2000(95):581-585.
35. Rao R.M., Yang L., Garcia-Cardena G., Luscinskas F.W. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circulation Res. 2007, 101:234-247.
36. Suzuki G., Iyer V., Lee T.-C., Canty J.M. Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium/novelty and significance. Circulation Res. 2011, 109:1044-1054.
37. Zhou G., Hamik A., Nayak L., Tian H., Shi H., Lu Y., Sharma N., Liao X., Hale A., Boerboom L., Feaver R.E., Gao H., Desai A., Schmaier A., Gerson S.L., Wang Y., Atkins G.B., Blackman B.R., Simon D.I., Jain M.K. Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice. J.Clin. Invest. 2012, 122:4727-4731.
38. Yamaguchi S., Yamahara K., Homma K., Suzuki S., Fujii S., Morizane R., Monkawa T., Matsuzaki Y., Kangawa K., Itoh H. The role of microRNA-145 in human embryonic stem cell differentiation into vascular cells. Atherosclerosis 2011, 219:468-474.
39. Li X., Song Y., Wang D., Fu C., Zhu Z., Han Y., Li C., Wang N., Zhu Y. LIF maintains progenitor phenotype of endothelial progenitor cells via Kruppel-like factor 4. Microvasc. Res. 2012, 84:270-277.